Promising gene therapy could transform heart failure treatment

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.

Alzheimer’s Gets New Galantamine Drug

The FDA approved oral benzgalantamine (Zunveyl) to treat symptoms of mild-to-moderate Alzheimer’s disease, Alpha Cognition announced on Monday. A prodrug of galantamine and an acetylcholinesterase

July 31, 2024

GSK receives FDA BTD for relapsed osteosarcoma treatment

Predominantly affecting children and young adults, osteosarcoma represents the most widespread primary bone cancer. Credit: Anciens Huang/Shutterstock. GSK has gained US Food and Drug Administration

January 8, 2025

Augmedix Launches GenAI-Powered, Medical Documentation Solution for Emergency Departments

What You Should Know: – Augmedix, a frontrunner in AI-powered medical documentation, has unveiled Augmedix Go – the first-ever fully automated GenAI solution designed specifically

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.